β-Cell Failure or β-Cell Abuse?
暂无分享,去创建一个
[1] B. Zinman,et al. Two‐year trial of intermittent insulin therapy vs metformin for the preservation of β‐cell function after initial short‐term intensive insulin induction in early type 2 diabetes , 2018, Diabetes, obesity & metabolism.
[2] Geoffrey S Johnson,et al. Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass , 2018, Diabetologia.
[3] J. Mar,et al. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults , 2018, Aging cell.
[4] S. Hunt,et al. Weight and Metabolic Outcomes 12 Years after Gastric Bypass , 2017, The New England journal of medicine.
[5] B. Corkey,et al. Hyperinsulinemia: a Cause of Obesity? , 2017, Current Obesity Reports.
[6] M. Kivimaki,et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study , 2017, Diabetologia.
[7] P. Zimmet. Diabetes and its drivers: the largest epidemic in human history? , 2017, Clinical Diabetes and Endocrinology.
[8] D. Feng,et al. Disproportionately Elevated Proinsulin Levels as an Early Indicator of β-Cell Dysfunction in Nondiabetic Offspring of Chinese Diabetic Patients , 2016, International journal of endocrinology.
[9] D. Flum,et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial , 2016, Diabetologia.
[10] N. Burritt,et al. Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets , 2016, PloS one.
[11] N. Burritt,et al. Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells* , 2015, The Journal of Biological Chemistry.
[12] M. Laakso,et al. Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: A Population-Based Study of 9,396 Finnish Men , 2015, PloS one.
[13] T. Lehtimäki,et al. Insulin and BMI as Predictors of Adult Type 2 Diabetes Mellitus , 2015, Pediatrics.
[14] G. Dohm,et al. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think. , 2014, Surgery.
[15] E. Aarts,et al. Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Diabetes Mellitus, Hypertension and Dyslipidaemia in Morbidly Obese Patients , 2014, Obesity Surgery.
[16] B. Corkey,et al. What Are We Putting in Our Food That Is Making Us Fat? Food Additives, Contaminants, and Other Putative Contributors to Obesity , 2014, Current Obesity Reports.
[17] R. Bergman,et al. Variable Hepatic Insulin Clearance with Attendant Insulinemia is the Primary Determinant of Insulin Sensitivity in the Normal Dog , 2013, Obesity.
[18] K. Thayer,et al. Environmental Chemicals and Type 2 Diabetes: An Updated Systematic Review of the Epidemiologic Evidence , 2013, Current Diabetes Reports.
[19] Kyla W. Taylor,et al. Evaluation of the Association between Persistent Organic Pollutants (POPs) and Diabetes in Epidemiological Studies: A National Toxicology Program Workshop Review , 2013, Environmental health perspectives.
[20] E. Levin,et al. Evaluation of the Association between Maternal Smoking, Childhood Obesity, and Metabolic Disorders: A National Toxicology Program Workshop Review , 2012, Environmental health perspectives.
[21] G. Dohm,et al. Diabetes: Have We Got It All Wrong? , 2012, Diabetes Care.
[22] A. Tenenbaum,et al. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? , 2012, Cardiovascular Diabetology.
[23] B. Corkey. Diabetes: Have We Got It All Wrong? , 2012, Diabetes Care.
[24] A. Tenenbaum,et al. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction , 2012, Cardiovascular Diabetology.
[25] Paloma Alonso-Magdalena,et al. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways , 2012, Molecular and Cellular Endocrinology.
[26] H. Daida,et al. Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study , 2012, Cardiovascular Diabetology.
[27] Terence Dwyer,et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. , 2011, The New England journal of medicine.
[28] S. Piccoli,et al. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. , 2011, The Journal of clinical endocrinology and metabolism.
[29] A. Rudich,et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. , 2011, The New England journal of medicine.
[30] Paloma Alonso-Magdalena,et al. Endocrine disruptors in the etiology of type 2 diabetes mellitus , 2011, Nature Reviews Endocrinology.
[31] W. Willett,et al. Childhood Size and Life Course Weight Characteristics in Association With the Risk of Incident Type 2 Diabetes , 2010, Diabetes Care.
[32] Hui-yu Liu,et al. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. , 2009, American journal of physiology. Endocrinology and metabolism.
[33] Mika Kivimäki,et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.
[34] S. Colagiuri,et al. Bimodal Distribution of Glucose Is Not Universally Useful for Diagnosing Diabetes , 2009, Diabetes Care.
[35] B. Strom,et al. Antidiabetic Action of Bezafibrate in a Large Observational Database , 2009, Diabetes Care.
[36] R. Bergman,et al. Metabolic syndrome, hyperinsulinemia, and cancer. , 2007, The American journal of clinical nutrition.
[37] D. Tanné,et al. Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes. , 2007, Atherosclerosis.
[38] M. Zdravkovic,et al. The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[39] H. Jörnvall,et al. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets. , 2007, The Journal of endocrinology.
[40] T. Jones,et al. Increasing body mass index z-score is continuously associated with complications of overweight in children, even in the healthy weight range. , 2007, The Journal of clinical endocrinology and metabolism.
[41] Y. Iwamoto,et al. Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1988, Diabetologia.
[42] J. Fruchart,et al. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. , 2006, Drugs of today.
[43] J. Kushner,et al. Very Slow Turnover of β-Cells in Aged Adult Mice , 2005 .
[44] T. Dyrberg,et al. The Effects of NN414, a SUR1/Kir6.2 Selective Potassium Channel Opener, in Healthy Male Subjects , 2005, Journal of clinical pharmacology.
[45] Masafumi Matsuda,et al. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.
[46] V. Grill,et al. Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes , 2004, Diabetologia.
[47] J. Sturis,et al. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats. , 2004, Metabolism: clinical and experimental.
[48] Johannes D. Veldhuis,et al. Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-Channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose , 2004 .
[49] M. Matsuda,et al. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man , 1994, Diabetologia.
[50] T. M. Szopa,et al. Coxsackie B4 viruses with the potential to damage Beta cells of the islets are present in clinical isolates , 1990, Diabetologia.
[51] J. Sturis,et al. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat. , 2003, Diabetes.
[52] C. Bogardus,et al. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. , 2000, Diabetes.
[53] N. Porksen,et al. Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. , 2000, American journal of physiology. Endocrinology and metabolism.
[54] R. Vigneri,et al. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. , 2000, Diabetes.
[55] M. Zemel,et al. Diazoxide down‐regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] P. Jones,et al. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. , 1999, The Journal of endocrinology.
[57] G. Boden,et al. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. , 1998, Diabetes.
[58] R. Alemzadeh,et al. Beneficial effect of diazoxide in obese hyperinsulinemic adults. , 1998, The Journal of clinical endocrinology and metabolism.
[59] P. Halban,et al. Proinsulin Conversion in GH3 Cells After Coexpression of Human Proinsulin With the Endoproteases PC2 and/or PC3 , 1997, Diabetes.
[60] R. Alemzadeh,et al. Antiobesity effect of diazoxide in obese Zucker rats. , 1996, Metabolism: clinical and experimental.
[61] G. Boden,et al. Effects of a 48-h Fat Infusion on Insulin Secretion and Glucose Utilization , 1995, Diabetes.
[62] G. Boden,et al. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. , 1995, The Journal of clinical investigation.
[63] S. Woods,et al. Intraventricular insulin and the level of maintained body weight in rats. , 1995, Behavioral neuroscience.
[64] J. Leahy,et al. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.
[65] L. Rossetti,et al. Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.
[66] P. Halban,et al. Kinetics of Proinsulin Conversion in Human Islets , 1993, Diabetes.
[67] T. Castonguay,et al. Effect of chronic insulin administration on food intake and body weight in rats , 1991, Physiology & Behavior.
[68] S. Woods,et al. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. , 1991, Endocrinology.
[69] M. Goubern,et al. Concomitant food intake and adipose tissue responses under chronic insulin infusion in rats , 1988, Physiology & Behavior.
[70] K. Polonsky,et al. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.
[71] W. Blackard,et al. Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. , 1978, Endocrinology.
[72] M. Laudat,et al. [Decreased number of insulin receptors in obesity: studies in the obese hyperglycemic mouse (author's transl)]. , 1976, Annales d'endocrinologie.
[73] C. Hales,et al. IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE , 1976, The Lancet.
[74] W. Blackard,et al. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. , 1975, The Journal of clinical investigation.
[75] D. Neville,et al. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. , 1974, Proceedings of the National Academy of Sciences of the United States of America.